Concepedia

Lavinia Pop

LP

Statistics

Publications

14

Citations

4.4K

H-Index

13

Active since

2010

Affiliations

Grigore T. Popa University of Medicine and Pharmacy(Current)

Alexandru Ioan Cuza University

University of Oradea

Eli Lilly (United States)

University of Washington

Lavinia Pop is an author at Grigore T. Popa University of Medicine and Pharmacy specializing in medicine, diabetes, and metabolic syndrome.

Top concepts

Publications per year

2010–2022

14

Publications

14

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

, , +9

Body-Esteem, Self-Esteem and Loneliness among Social Media Young Users

Lavinia Pop, Magdalena Iorga, Raluca Iurcov · International Journal of Environmental Research and Public Health · 2022 · 85 citations · Full text

A placebo‐controlled trial of exenatide twice‐daily added to thiazolidinediones alone or in combination with metformin

Joanne Liutkus, Juan Rosas Guzmán, Paul Norwood et al. · Diabetes Obesity and Metabolism · 2010 · 75 citations · Full text

1–5 of 14